Authors: Oficialdegui, AM Martinez, J Perez, S Heras, B Irurzun, M Palop, JA Tordera, R Lasheras, B del Rio, J Monge, A

Citation: Am. Oficialdegui et al., Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual modeof action: serotonin reuptake inhibition and 5-HT1A receptor antagonism, FARMACO, 55(5), 2000, pp. 345-353